Gemma Cut The Cramp Tablet, Effervescent
NDC Package 75920-0465-2
Package Information
Gemma Cut The Cramp (aspirin, caffeine) tablets is classified as a
Identification & Billing
- RxCUI: 1537019 - aspirin 500 MG / caffeine 60 MG Effervescent Oral Tablet
- RxCUI: 1537019 - ASA 500 MG / Caffeine 60 MG Effervescent Oral Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
- Central Nervous System Stimulation - [PE] (Physiologic Effect)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Methylxanthine - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Xanthines - [CS]
Regulatory & Marketing
Hierarchy Structure
- 75920 - Rally Labs Llc
- 75920-0465 - Gemma Cut The Cramp
- 75920-0465-2 - 20 POUCH in 1 CARTON / 6816 mg in 1 POUCH
- 75920-0465 - Gemma Cut The Cramp
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 75920-0465-2 identifies a specific commercial package of 20 pouch in 1 carton / 6816 mg in 1 pouch of Gemma Cut The Cramp, a human over the counter drug labeled by Rally Labs Llc. This tablet, effervescent is formulated for oral use and contains aspirin; caffeine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rally Labs Llc on April 23, 2024. The current certification is valid through December 31, 2026.
How is this Rally Labs Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 75920046502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.